Want to see CASIF full AI Analyst Report?
CASI Pharmaceuticals (CASIF) Financial Statements
CASI Pharmaceuticals Financial Overview
CASI Pharmaceuticals's market cap is currently $2.67M. The company's EPS TTM is $-2.28; its P/E ratio is -0.06; CASI Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 20.71M | $ 28.54M | $ 33.88M | $ 43.11M | $ 30.17M |
| Gross Profit | $ 10.06M | $ 11.15M | $ 20.05M | $ 27.28M | $ 17.61M |
| Operating Income | $ -42.85M | $ -39.62M | $ -25.08M | $ -26.49M | $ -41.52M |
| EBITDA | $ -43.77M | $ -34.87M | $ -21.54M | $ -35.79M | $ -33.40M |
| Net Income | $ -48.06M | $ -39.26M | $ -26.94M | $ -41.01M | $ -36.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.63M | $ 16.09M | $ 30.77M | $ 51.34M | $ 48.57M |
| Total Assets | $ 25.65M | $ 53.67M | $ 75.27M | $ 96.23M | $ 138.30M |
| Total Debt | $ 27.49M | $ 22.14M | $ 21.24M | $ 1.34M | $ 4.33M |
| Net Debt | $ 21.85M | $ 8.67M | $ 4.16M | $ -45.77M | $ -34.37M |
| Total Liabilities | $ 62.93M | $ 51.82M | $ 51.10M | $ 29.30M | $ 30.34M |
| Stockholders' Equity | $ -37.28M | $ 1.85M | $ 24.16M | $ 44.57M | $ 84.50M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.77M | $ -29.46M | $ -22.21M | $ -26.70M | $ -42.34M |
| Operating Cash Flow | $ -20.75M | $ -29.22M | $ -19.97M | $ -21.09M | $ -26.84M |
| Investing Cash Flow | $ 951.00K | $ 11.24M | $ -9.67M | $ 31.16M | $ -20.69M |
| Financing Cash Flow | $ 11.25M | $ 15.43M | $ -907.00K | $ -3.27M | $ 29.64M |
Currency in USD